Bajaj Healthcare forays into highly-regulated opiate processing business

Bajaj Healthcare said it has received two orders from the central government to produce active pharmaceutical ingredients (API) from poppy capsules and other derivatives on an annual basis

Healthcare, health, public health, insurance
Representative Image
Press Trust of India New Delhi
1 min read Last Updated : Jul 13 2022 | 1:34 PM IST

Bajaj Healthcare on Wednesday said it has forayed into the highly regulated opiate processing business.

The company said it has received two orders from the central government to produce active pharmaceutical ingredients (API) from poppy capsules and other derivatives on an annual basis.

It plans to execute both these tenders from its API manufacturing unit located at Savli, Gujarat.

"We have been awarded two tenders for the supply of Opium derived Alkaloids and APIs to the GOI, under long-term contracts and expect successive orders under similar tenders to scale up to the processing of 6,000 MT of Poppy Straw and Opium Gum in the next five years," Bajaj Healthcare Joint Managing Director Anil Jain said in a regulatory filing.

The Indian opiate market holds good potential and the receipt of this order opens the doors to a new business vertical with better margins, he added.

"This is for the first time in the history of the nation that the government has deregulated Opiate Processing to a private player, and we are extremely honoured to be awarded the very first tender in this segment," Jain said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :BajajIndian healthcarePharmaceutical

First Published: Jul 13 2022 | 1:34 PM IST

Next Story